Cyclerion Therapeutics, Inc.Recognition Bonus Agreement • March 5th, 2024 • Cyclerion Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 5th, 2024 Company Industry JurisdictionThis letter agreement (this “Agreement”) between you and Cyclerion Therapeutics, Inc. (the “Company”) amends and restates the prior retention bonus letter agreement, dated October 3, 2022, between you and the Company, with respect to your opportunity to earn a Recognition Bonus (as defined below). The Company is offering you this opportunity in recognition of your importance to the continued success of the Company.
Cyclerion Therapeutics, Inc.Recognition Bonus Agreement • March 5th, 2024 • Cyclerion Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 5th, 2024 Company Industry JurisdictionThis letter agreement (this “Agreement”) between you and Cyclerion Therapeutics, Inc. (the “Company”) amends and restates the prior retention bonus letter agreement, dated October 3, 2022, between you and the Company, with respect to your opportunity to earn a Recognition Bonus (as defined below). The Company is offering you this opportunity in recognition of your importance to the continued success of the Company.
Cyclerion Therapeutics, Inc.Recognition Bonus Agreement • March 22nd, 2023 • Cyclerion Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 22nd, 2023 Company Industry JurisdictionThis letter agreement (this “Agreement”) between you and Cyclerion Therapeutics, Inc. (the “Company”) amends and restates the prior retention bonus letter agreement, dated October 3, 2022, between you and the Company, with respect to your opportunity to earn a Recognition Bonus (as defined below). The Company is offering you this opportunity in recognition of your importance to the continued success of the Company.
Cyclerion Therapeutics, Inc.Recognition Bonus Agreement • March 22nd, 2023 • Cyclerion Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledMarch 22nd, 2023 Company Industry JurisdictionThis letter agreement (this “Agreement”) between you and Cyclerion Therapeutics, Inc. (the “Company”) amends and restates the prior retention bonus letter agreement, dated October 3, 2022, between you and the Company, with respect to your opportunity to earn a Recognition Bonus (as defined below). The Company is offering you this opportunity in recognition of your importance to the continued success of the Company.